Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its ...

Pfizer PFE is one of the largest and most successful drugmakers in oncology. It boasts a strong portfolio of approved cancer ...

Pfizer stock offers 30% upside with strong non-COVID franchises, margin expansion, and pipeline potential. Click here to read ...

Pfizer’s VC arm has backed a $100 million series A raise for OTR Therapeutics, as the Chinese biotech tacks on preclinical ...

Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded the state's Medicaid program over alleged quality control lapses in a ...

Drugmaker Pfizer has agreed to lower drug costs under a deal struck with the Trump administration, President Donald Trump said Tuesday, as he promised similar deals will be struck with other ...

And one of them is pharmaceutical giant Pfizer ( PFE 0.04%). Now, with a major step along the path to entering this ...

Government lawyer ignores leaked memo from FDA vaccines chief as she tries to convince appeals court to block Brook Jackson ...

Pfizer (PFE) stock is in focus as the firm joins Tris Pharma to settle a lawsuit over supplying an adulterated ADHD drug to children on Texas Medicaid. Read more here.

President Donald Trump announced Tuesday that his administration has reached a deal with Pfizer for it to voluntarily sell its drugs at lower prices to Medicaid patients. As part of the deal, Trump ...

Pfizer and Merck are two of the largest drug companies on the planet. Both companies are dealing with upcoming patent expirations. Pfizer is making aggressive moves to solve the problem, which is ...